These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis, cytotoxicity, antiviral activity and interferon inducing ability of 6-(2-aminoethyl)-6H-indolo[2,3-b]quinoxalines. Shibinskaya MO; Lyakhov SA; Mazepa AV; Andronati SA; Turov AV; Zholobak NM; Spivak NY Eur J Med Chem; 2010 Mar; 45(3):1237-43. PubMed ID: 20056519 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antifungal activities of novel 5,6-dihydro-indolo[1,2-a]quinoxaline derivatives. Xu H; Fan LL Eur J Med Chem; 2011 May; 46(5):1919-25. PubMed ID: 21388718 [TBL] [Abstract][Full Text] [Related]
4. Interactions of the antiviral quinoxaline derivative 9-OH-B220 [2, 3-dimethyl-6-(dimethylaminoethyl)- 9-hydroxy-6H-indolo-[2, 3-b]quinoxaline] with duplex and triplex forms of synthetic DNA and RNA. Sehlstedt U; Aich P; Bergman J; Vallberg H; Nordén B; Gräslund A J Mol Biol; 1998 Apr; 278(1):31-56. PubMed ID: 9571032 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives. Moorthy NS; Karthikeyan C; Trivedi P J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners. Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378 [TBL] [Abstract][Full Text] [Related]
7. 6H-Indolo[2,3-b]quinoxalines: DNA and protein interacting scaffold for pharmacological activities. Moorthy NS; Manivannan E; Karthikeyan C; Trivedi P Mini Rev Med Chem; 2013 Aug; 13(10):1415-20. PubMed ID: 23701655 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives. Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents. Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization, and Biological Evaluation of Some Novel Quinoxaline Derivatives as Antiviral Agents. El-Zahabi HSA Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28407276 [TBL] [Abstract][Full Text] [Related]
12. Interactions of antiviral indolo[2,3-b]quinoxaline derivatives with DNA. Wilhelmsson LM; Kingi N; Bergman J J Med Chem; 2008 Dec; 51(24):7744-50. PubMed ID: 19053744 [TBL] [Abstract][Full Text] [Related]
13. Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities. Riou JF; Fossé P; Nguyen CH; Larsen AK; Bissery MC; Grondard L; Saucier JM; Bisagni E; Lavelle F Cancer Res; 1993 Dec; 53(24):5987-93. PubMed ID: 8261412 [TBL] [Abstract][Full Text] [Related]
14. Quinoxaline derivatives as new inhibitors of coxsackievirus B5. Carta A; Sanna G; Briguglio I; Madeddu S; Vitale G; Piras S; Corona P; Peana AT; Laurini E; Fermeglia M; Pricl S; Serra A; Carta E; Loddo R; Giliberti G Eur J Med Chem; 2018 Feb; 145():559-569. PubMed ID: 29339251 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted chromeno[2,3-b]indoles. Peng W; Świtalska M; Wang L; Mei ZW; Edazawa Y; Pang CQ; El-Tantawy El-Sayed I; Wietrzyk J; Inokuchi T Eur J Med Chem; 2012 Dec; 58():441-51. PubMed ID: 23151321 [TBL] [Abstract][Full Text] [Related]
16. Combined directed ortho and remote metalation-cross-coupling strategies. General method for benzo[a]carbazoles and the synthesis of an unnamed indolo[2,3-a]carbazole alkaloid. Cai X; Snieckus V Org Lett; 2004 Jul; 6(14):2293-5. PubMed ID: 15228262 [TBL] [Abstract][Full Text] [Related]
17. Pt(IV)-catalyzed hydroamination triggered cyclization: a strategy to fused pyrrolo[1,2-a]quinoxalines, indolo[1,2-a]quinoxalines, and indolo[3,2-c]quinolines. Patil NT; Kavthe RD; Shinde VS; Sridhar B J Org Chem; 2010 May; 75(10):3371-80. PubMed ID: 20392052 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents. Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents. Jaso A; Zarranz B; Aldana I; Monge A J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444 [TBL] [Abstract][Full Text] [Related]
20. DNA interaction and cytotoxicity of a new series of indolo[2,3-b]quinoxaline and pyridopyrazino[2,3-b]indole derivatives. Arimondo PB; Baldeyrou B; Laine W; Bal C; Alphonse FA; Routier S; Coudert G; Mérour JY; Colson P; Houssier C; Bailly C Chem Biol Interact; 2001 Oct; 138(1):59-75. PubMed ID: 11640915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]